Liangyan Peng

Title: Innovations in Anticancer Drug Development by Liangyan Peng

Introduction

Liangyan Peng is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer drugs. His innovative work focuses on creating drug formulations that enhance therapeutic efficacy while minimizing adverse effects.

Latest Patents

Liangyan Peng holds a patent for an "Intermediate drug with synergistic anticancer activity and polyethylene glycol-coupled synergistic anticancer drug, and preparation method therefor and use thereof." This patent describes an intermediate drug that exhibits synergistic anticancer activity, along with a polyethylene glycol-coupled drug. The invention aims to facilitate the combined medication of various anticancer drugs, thereby avoiding toxic reactions and overcoming multidrug resistance in cancers. The drugs are designed to enhance the effectiveness of anticancer treatments while reducing side effects.

Career Highlights

Liangyan Peng is associated with Chongqing Upgra Biotechnology Co., Ltd., where he continues to advance his research in drug development. His work is characterized by a commitment to improving cancer treatment options through innovative pharmaceutical solutions.

Collaborations

Liangyan has collaborated with colleagues such as Tingting He and Jianhuan Li, contributing to a dynamic research environment focused on groundbreaking advancements in biotechnology.

Conclusion

Liangyan Peng's contributions to the field of anticancer drug development highlight the importance of innovation in improving treatment outcomes for cancer patients. His work exemplifies the potential of synergistic drug formulations in enhancing therapeutic efficacy.